| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BLUE BUFFALO PET PRODS INC | 114,987,547 | 2,683,809,000 | 55.40% | ||
| 2 | LEXICON PHARMACEUTICALS | 57,517,977 | 825,383,000 | 17.04% | ||
| 3 | WEIGHT WATCHERS INTL INC | 29,443,300 | 342,426,000 | 7.07% | ||
| 4 | GOLDMAN SACHS GROUP INC | 1,250,000 | 185,725,000 | 3.83% | Call | |
| 5 | BANK AMER CORP | 5,000,000 | 66,350,000 | 1.37% | Call | |
| 6 | INCYTE | 625,000 | 49,988,000 | 1.03% | ||
| 7 | REGENERON PHARMACEUTICALS | 120,000 | 41,908,000 | 0.87% | Call | |
| 8 | ALNYLAM PHARMACEUTICALS INC | 710,000 | 39,398,000 | 0.81% | ||
| 9 | WAL-MART STORES INC | 500,000 | 36,510,000 | 0.75% | Call | |
| 10 | BIOGEN INC | 150,000 | 36,273,000 | 0.75% | Call | |
| 11 | ALIBABA GROUP HLDG LTD | 400,000 | 31,812,000 | 0.66% | ||
| 12 | GOLDMAN SACHS GROUP INC | 200,000 | 29,716,000 | 0.61% | ||
| 13 | ALPHABET INC | 40,000 | 28,141,000 | 0.58% | Call | |
| 14 | BIOMARIN | 350,000 | 27,230,000 | 0.56% | ||
| 15 | NEKTAR THERAPEUTICS COM | 1,400,000 | 19,922,000 | 0.41% | ||
| 16 | METLIFE INC | 500,000 | 19,915,000 | 0.41% | Call | |
| 17 | CELGENE CORP | 200,000 | 19,726,000 | 0.41% | Call | |
| 18 | BLUEBIRD BIO INCORPORATED | 450,000 | 19,481,000 | 0.40% | ||
| 19 | REGENERON PHARMACEUTICALS | 50,000 | 17,462,000 | 0.36% | ||
| 20 | DELPHI AUTOMOTIVE PLC | 275,000 | 17,215,000 | 0.36% | ||
| 21 | ALNYLAM PHARMACEUTICALS INC | 300,000 | 16,647,000 | 0.34% | Call | |
| 22 | KITE PHARMA INCORPORATED | 325,000 | 16,250,000 | 0.34% | ||
| 23 | TESLA INC | 75,000 | 15,921,000 | 0.33% | ||
| 24 | AGIOS PHARMACEUTICALS INC | 375,000 | 15,711,000 | 0.32% | ||
| 25 | JPMORGAN CHASE & CO | 250,000 | 15,535,000 | 0.32% | Call | |
| 26 | INTERNATIONAL BUSINESS MACHS | 100,000 | 15,178,000 | 0.31% | Call | |
| 27 | BANK AMER CORP | 1,100,000 | 14,597,000 | 0.30% | ||
| 28 | ARRAY BIOPHARMA INC COM | 3,870,000 | 13,777,000 | 0.28% | ||
| 29 | VERTEX PHARMACEUT | 150,000 | 12,903,000 | 0.27% | Call | |
| 30 | US FOODS HLDG CORP | 500,000 | 12,120,000 | 0.25% | ||
| 31 | CITIGROUP INC | 250,000 | 10,598,000 | 0.22% | ||
| 32 | MORGAN STANLEY | 400,000 | 10,392,000 | 0.21% | ||
| 33 | METLIFE INC | 250,000 | 9,958,000 | 0.21% | ||
| 34 | SERES THERAPEUTICS INC | 310,000 | 9,006,000 | 0.19% | ||
| 35 | JUNO THERAPEUTICS INCORPORATED | 200,000 | 7,688,000 | 0.16% | ||
| 36 | AMICUS THERAPEUTICS INC | 1,250,000 | 6,825,000 | 0.14% | ||
| 37 | SPECTRANETICS CORP | 350,000 | 6,549,000 | 0.14% | ||
| 38 | AVEXIS INC COM | 161,900 | 6,155,000 | 0.13% | ||
| 39 | HORIZON PHARMA PLC | 350,000 | 5,765,000 | 0.12% | ||
| 40 | CELLECTIS S A | 210,000 | 5,584,000 | 0.12% | ||
| 41 | JD COM INC ADR | 250,000 | 5,308,000 | 0.11% | Call | |
| 42 | INTELLIA THERAPEUTICS INC | 225,000 | 4,804,000 | 0.10% | ||
| 43 | BLUEBIRD BIO INCORPORATED | 100,000 | 4,329,000 | 0.09% | Call | |
| 44 | NEUROCRINE BIOSCIE COM USD0.001 | 95,000 | 4,318,000 | 0.09% | ||
| 45 | IGNYTA INC COM | 750,000 | 4,065,000 | 0.08% | ||
| 46 | AGENUS INC | 1,000,000 | 4,050,000 | 0.08% | ||
| 47 | CHEMOCENTRYX INC | 900,000 | 4,041,000 | 0.08% | ||
| 48 | RADIUS HEALTH | 100,000 | 3,675,000 | 0.08% | ||
| 49 | RADIUS HEALTH | 100,000 | 3,675,000 | 0.08% | Call | |
| 50 | ULTRAGENYX PHARMACEUTICAL INC COM | 75,000 | 3,668,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-075939, filed 2016.08.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
